BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 11417136)

  • 21. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.
    Hannaoui S; Maatouk L; Privat N; Levavasseur E; Faucheux BA; Haïk S
    J Virol; 2013 Mar; 87(5):2535-48. PubMed ID: 23255799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmission of prion disease.
    Blättler T
    APMIS; 2002 Jan; 110(1):71-8. PubMed ID: 12064258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
    Telling GC; Parchi P; DeArmond SJ; Cortelli P; Montagna P; Gabizon R; Mastrianni J; Lugaresi E; Gambetti P; Prusiner SB
    Science; 1996 Dec; 274(5295):2079-82. PubMed ID: 8953038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.
    Jiménez-Huete A; Lievens PM; Vidal R; Piccardo P; Ghetti B; Tagliavini F; Frangione B; Prelli F
    Am J Pathol; 1998 Nov; 153(5):1561-72. PubMed ID: 9811348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein functions and dysfunction in prion diseases.
    Sakudo A; Ikuta K
    Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
    Prusiner SB; Stahl N; DeArmond SJ
    Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prions and prion proteins.
    Stahl N; Prusiner SB
    FASEB J; 1991 Oct; 5(13):2799-807. PubMed ID: 1916104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture.
    Brown DR; Schmidt B; Kretzschmar HA
    Glia; 1996 Sep; 18(1):59-67. PubMed ID: 8891692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
    Pietri M; Caprini A; Mouillet-Richard S; Pradines E; Ermonval M; Grassi J; Kellermann O; Schneider B
    J Biol Chem; 2006 Sep; 281(38):28470-9. PubMed ID: 16864581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotoxicity of a prion protein fragment.
    Forloni G; Angeretti N; Chiesa R; Monzani E; Salmona M; Bugiani O; Tagliavini F
    Nature; 1993 Apr; 362(6420):543-6. PubMed ID: 8464494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation of cellular prion protein to non-lipid rafts protects human prion-mediated neuronal damage.
    Jeong JK; Moon MH; Lee YJ; Seol JW; Park SY
    Int J Mol Med; 2012 Mar; 29(3):387-92. PubMed ID: 22179431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the role of dendritic cells in prion transfer to primary neurons.
    Langevin C; Gousset K; Costanzo M; Richard-Le Goff O; Zurzolo C
    Biochem J; 2010 Oct; 431(2):189-98. PubMed ID: 20670217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.